Literature DB >> 21215910

Risk factors and outcomes of Guillain-Barré syndrome with acute myelitis.

Jainn-Jim Lin1, Shao-Hsuan Hsia, Chang-Teng Wu, Huei-Shyong Wang, Kuang-Lin Lin, Rong-Kuo Lyu.   

Abstract

Guillain-Barré syndrome and acute myelitis represent common and very rare etiologies of acute limb weakness in children, respectively. Typically, demyelination is most common, limited to either the central or peripheral nervous system. Concurrent acute myelitis and Guillain-Barré syndrome are seldom reported. We retrospectively reviewed cases of Guillain-Barré syndrome in Chang Gung Children's Hospital from 2000-2008. The risk factors of Guillain-Barré syndrome with or without acute myelitis were analyzed. Thirty-six children with Guillain-Barré syndrome were enrolled. Five children manifested coexisting acute myelitis. In the disease's earliest stage, differentiating concurrent acute myelitis and Guillain-Barré syndrome from Guillain-Barré syndrome only was difficult. Four of 5 children were aged more than 8 years. All patients developed a sharply defined sensory level, and manifested severe bladder dysfunction. Autonomic dysfunction was evident in three patients. All children with sufficient follow-up continued to demonstrate residual paresis, and two demonstrated significant long-term motor deficits. Detection of a sharply defined sensory level, severe bladder dysfunction, and autonomic dysfunction can be helpful in recognizing concurrent acute myelitis. Therefore, recognition of this combination of peripheral and central nervous inflammation early is important for determining prognoses and perhaps initial treatment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21215910     DOI: 10.1016/j.pediatrneurol.2010.08.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  1 in total

1.  Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections.

Authors:  Thomas Langerak; Irene van Rooij; Laura Doornekamp; Felicity Chandler; Mark Baptista; Harvey Yang; Marion P G Koopmans; Corine H GeurtsvanKessel; Bart C Jacobs; Barry Rockx; Kirsten Adriani; Eric C M van Gorp
Journal:  Front Neurol       Date:  2021-02-10       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.